Daily FNArena News - Small Caps

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market

Analysts raise target prices for SiteMinder after management brings forward the time frame for being free cash flow positive

Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports

Analysts remain positive on Syrah Resources despite current weak market conditions for graphite

Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics

Skin repair specialist PolyNovo remains confident in its firm growth path ahead

New research highlights Retail Food Group’s resilience to a consumer downturn and several capital-light growth opportunities

Brokers explain a negative share price reaction to Johns Lyng’s upgraded FY23 guidance

Recent research on Macquarie Technology shows a strong near-term cloud demand outlook and a significant growth profile in coming years

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand